1. Laboratory
  2. Laboratory medicine
  3. Genetic mutation test kit
  4. Jiangsu Macro micro-test Medical Technology

Genetic mutation detection kit HWTS-RT074B
Mycobacterium tuberculosissputumfluorescence

Genetic mutation detection kit - HWTS-RT074B - Jiangsu Macro micro-test Medical Technology - Mycobacterium tuberculosis / sputum / fluorescence
Genetic mutation detection kit - HWTS-RT074B - Jiangsu Macro micro-test Medical Technology - Mycobacterium tuberculosis / sputum / fluorescence
Genetic mutation detection kit - HWTS-RT074B - Jiangsu Macro micro-test Medical Technology - Mycobacterium tuberculosis / sputum / fluorescence - image - 2
Genetic mutation detection kit - HWTS-RT074B - Jiangsu Macro micro-test Medical Technology - Mycobacterium tuberculosis / sputum / fluorescence - image - 3
Add to favorites
Compare this product
 

Characteristics

Applications
for genetic mutations
Tested parameter
Mycobacterium tuberculosis
Sample type
sputum
Analysis mode
fluorescence, for RT-PCR
Result display time

Max.: 90 min

Min.: 60 min

Description

This kit is suitable for the qualitative detection of Mycobacterium tuberculosis DNA in human sputum samples in vitro, as well as the homozygous mutation in the 507-533 amino acid codon region of the rpoB gene that causes Mycobacterium tuberculosis rifampicin resistance. Epidemiology Mycobacterium tuberculosis , shortly as Tubercle bacillus, TB, is the pathogenic bacterium that causes tuberculosis. Currently, the commonly used first-line anti-tuberculosis drugs include isoniazid, rifampicin and hexambutol, etc. The second-line anti-tuberculosis drugs include fluoroquinolones, amikacin and kanamycin, etc. The new developed drugs are linezolid, bedaquiline and delamani, etc. However, due to the incorrect use of anti-tuberculosis drugs and the characteristics of the cell wall structure of mycobacterium tuberculosis, mycobacterium tuberculosis develops drug resistance to anti-tuberculosis drugs, which brings serious challenges to the prevention and treatment of tuberculosis. Rifampicin has been widely used in the treatment of pulmonary tuberculosis patients since the late 1970s, and has a significant effect. It has been the first choice to shorten the chemotherapy of pulmonary tuberculosis patients.

Catalogs

Other Jiangsu Macro micro-test Medical Technology products

FLUORESCENCE PCR

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.